Buy or Sell a Detox or Residential Treatment Center

What buyers actually pay for in detox and residential

Adjusted EBITDA is the starting point, but the multiple is not set by the EBITDA line on its own. Two facilities can post the same earnings and transact at materially different levels, because what a buyer is really buying is the durability of that earnings stream. The variables that move the number most:

• Breadth of the continuum. A facility licensed for detox only is a narrower business than one that carries detox, residential, and a step-down into PHP or IOP. The longer a patient stays inside your program, the more revenue per admission, and the more defensible the census.
• Payer mix and authorization quality. Commercial and in-network revenue is worth more than a Medicaid-heavy book at the same topline, but only where the authorizations and documentation support what is being billed. A payer audit that finds gaps converts premium revenue into a price reduction.
• Census durability rather than headline census. Buyers want twelve to twenty-four months of trend, not a strong trailing quarter. Referral concentration is the usual reason a facility looks stable and is not.
• Clinical and medical leadership. A medical director who is also the owner is a dependency, not an asset, unless there is a written succession arrangement. In residential, the team is the business.
• The real estate and the lease. Owned property, a related-party lease, and an arm's-length lease produce three different structures and three different buyer pools. Remaining lease term and landlord identity matter as much as rent.

What a detox or residential facility is worth

There is no single multiple for this asset class, and any adviser who quotes one before seeing your financials is guessing. Small, single-site, Medicaid-concentrated facilities sit at one end of the range. Larger, commercially insured facilities with a full continuum, clean documentation, and stable clinical leadership sit at the other. Real estate included or excluded moves the answer again.

What we do instead is build the number from the inside: normalize add-backs and owner compensation, test the census and payer trends against the claimed run-rate, and then benchmark the result against what comparable facilities have actually closed at. That produces a defensible range you can plan around, rather than a headline figure designed to win the engagement.

What reprices or kills a detox transaction

Most value is lost before the business reaches the market. The recurring causes:

• Payer concentration. One contract carrying too much of the revenue turns a business sale into a contract renewal bet.
• Documentation that does not support billed revenue. Quality-of-earnings review will find it, and the buyer will price the exposure.
• A census decline the seller did not explain. Unexplained movement reads as a trend; explained movement reads as a decision.
• Survey and licensure history. An open plan of correction is a discount until it is closed.
• Owner dependence. Clinical, referral, and administrative functions concentrated in one person cap the multiple regardless of earnings.

How long it takes to sell a detox facility

Preparation typically runs three to six months where the financials or documentation need work, and the transaction itself commonly takes four to nine months from engagement to close. Change-of-ownership approval and the license transfer usually set the pace, not the financial diligence — which is why the licensing work is started early rather than after a letter of intent.

If you want to know what your facility would be worth and what would move the number, start with valuation and exit planning.